GGrantIndex
Sort

17,828 grants matching crispr

Expanding Excellence in Developmental Biology in Oklahoma

$158,542
Jyoti Iyer · Oklahoma Medical Research Foundation · P20 · FY2021 · GM

Genomic Conflict Resolution: Establishment of a new model for unconstrained germline selection

$158,509
Matthew Theodor Biegler · Rockefeller University · K99 · FY2025 · HG

AN INDUCIBLE CRISPR PLATFORM FOR ORTHOGONAL CONTROL OF GENE EXPRESSION IN LUNG CANCER FORMATION

$158,500
Regents Of The University Of California, San Francisco, The · · FY2018 · Department of the Army

Functional characterization of the telomere repeat containing RNA, TERRA, in telomere maintenance

$158,463
Rachel L. Flynn · Boston University Medical Campus · R01 · FY2022 · CA

A Pathogenic Role for Natriuretic Peptide Receptor-C in Pulmonary Hypertension and Heart Failure with Preserved Ejection Fraction

$158,436
Vineet Agrawal · Vanderbilt University Medical Center · K08 · FY2022 · HL

A Pathogenic Role for Natriuretic Peptide Receptor-C in Pulmonary Hypertension and Heart Failure with Preserved Ejection Fraction

$158,436
Vineet Agrawal · Vanderbilt University Medical Center · K08 · FY2021 · HL

Oncogenic Roles and Therapeutic Potential of MCL1 Addiction in Primary Effusion Lymphoma

$158,397
Mark Manzano · Univ Of Arkansas For Med Scis · K22 · FY2021 · CA

Oncogenic Roles and Therapeutic Potential of MCL1 Addiction in Primary Effusion Lymphoma

$158,397
Mark Manzano · Univ Of Arkansas For Med Scis · K22 · FY2022 · CA

Examining the Equitable Integration of Genomics in Health Care and Society

$158,170
Vence L Bonham · National Human Genome Research Institute · ZIA · FY2021 · HG

Project 2: Regulation of Rotavirus Host Range, Neutralization, and M cell Interactions in Enteric Biomimetics

$157,880
Harry Bernard Greenberg · Stanford University · U19 · FY2023 · AI

Methods for mammalian genetic analysis

$157,827
Ji Luo · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA

Developing a murine TPI Df model

$157,750
Michael John Palladino · University Of Pittsburgh At Pittsburgh · R03 · FY2021 · NS

Regulation of Signaling Pathways Involving Nuclear Factor Kappa B

$157,742
Michael J Lenardo · National Institute Of Allergy And Infectious Diseases · ZIA · FY2022 · AI

Defining the Biology of the ADAR1-RISC Complex

$157,635
Benjamin R. Tenoever · New York University School Of Medicine · R01 · FY2023 · AI

Overcoming sexually dimorphic barriers to viral gene therapy for treating genetic liver diseases

$157,569
Nicole K Paulk · University Of California, San Francisco · K01 · FY2018 · DK

Overcoming sexually dimorphic barriers to viral gene therapy for treating genetic liver diseases

$157,569
Nicole K Paulk · University Of California, San Francisco · K01 · FY2020 · DK

Overcoming sexually dimorphic barriers to viral gene therapy for treating genetic liver diseases

$157,569
Nicole K Paulk · University Of California, San Francisco · K01 · FY2019 · DK

Genomics Shared Resource

$157,563
Dan Theodorescu · University Of Colorado Denver · P30 · FY2017 · CA

Imaging the metabolic and phagocytic landscape of microglia in Alzheimer’s disease

$157,525
Sarah C Heilshorn · Stanford University · R03 · FY2021 · AG

PROMINENT - Stanford

$157,520
Emma Lundberg · Stanford University · OT2 · FY2024 · CA

An inducible molecular memory system to unravel the mechanisms of drug resistance in head and neck cancer

$157,500
Sidharth Venkata Puram · Washington University · R21 · FY2023 · DE

Imaging the metabolic and phagocytic landscape of microglia in Alzheimer’s disease

$157,400
Sarah C Heilshorn · Stanford University · R03 · FY2022 · AG

AR-V7 Acetylation in Castration Resistant Prostate Cancer

$157,294
Wanguo Liu · Lsu Health Sciences Center · R21 · FY2019 · CA

Investigating roles for transcriptional co-activators Eya2 and Eya3 in normal development and rhabdomyosarcoma

$157,268
Jenean O'Brien · College Of St Scholastica · R15 · FY2017 · CA

Engineering and validation of two conditional multi-gene mouse models of skeletal development

$157,176
Kimberly L Cooper · University Of California, San Diego · R21 · FY2021 · AR